Matthew Hemstreet Named CEO of KROMATID as Company Targets Growth in Cell and Gene Therapy Market

KROMATID has appointed Matthew Hemstreet as chief executive officer, succeeding interim CEO Terry Opgenorth as the company looks to expand... Read More

The post Matthew Hemstreet Named CEO of KROMATID as Company Targets Growth in Cell and Gene Therapy Market appeared first on citybiz.